Found 17 Multiple Myeloma trials
A listing of Multiple Myeloma medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.
Sort by:
The primary purpose of this research study is to obtain specimens (blood, bone marrow, and other tissues) for research about multiple myeloma and related diseases.
This study investigates the long-term safety of an investigational medication known as cilta-cel, which is a type of CAR-T cell therapy. Specifically, cilta-cel targets a protein called B-cell maturation antigen (BCMA) found on certain cancer cells.Participants in this study will not receive any treatment. Instead, the study will collect data …
The purpose of this study is to learn how participant factors (such as medical history and manufacturing starting material, also known as Apheresis) can predict successful manufacturing of ciltacabtagene autoleucel (Cilta-cel). This information can be used to potentially improve manufacturing processes and treat more patients with Cilta-cel. We would like …
Study on Investigational Medication for Relapsed or Refractory Plasma Cell Cancer (Multiple Myeloma)
This study investigates the effects of an investigational medication on individuals with relapsed or refractory multiple myeloma. The purpose of the study is to evaluate the safety, tolerability, and effectiveness of the investigational medication when used alone or in combination with other cancer treatments.Participants in the study will receive the …
This study investigates the effects of an investigational medication on patients with relapsed and refractory multiple myeloma (RRMM). The purpose of the study is to evaluate the safety and effects of a selective inhibitor that targets a specific enzyme involved in the disease process.Participants will undergo a dose-escalation phase to …
This study investigates the safety of an investigational treatment using allogeneic T stem cell memory (Tscm) CAR-T cells in patients with relapsed or refractory Multiple Myeloma (RRMM). The study involves different parts, including dose escalation to find a safe dose and fixed-dose administration to see how the treatment works.Participants will …
This study investigates the effects of different maintenance therapies in people with newly diagnosed multiple myeloma. The purpose of this study is to compare the investigational medication teclistamab in combination with lenalidomide, teclistamab alone, and lenalidomide alone in maintaining health after a stem cell transplant.Participants will be randomly assigned to …
This study investigates a limited-duration therapy approach for patients with relapsed refractory multiple myeloma who have shown a very good partial response or better after receiving teclistamab. This study aims to determine if stopping teclistamab treatment after 6 to 9 months is as effective as continuous treatment in preventing disease …
This study investigates the use of an investigational treatment for patients with multiple myeloma. The purpose of this study is to provide access to ciltacabtagene autoleucel, a treatment that is not available through the local healthcare system, for patients whose condition is serious or life-threatening and who cannot use other …
This study investigates relapsed or refractory multiple myeloma.The study evaluates the effectiveness of an investigational medication in participants who have received at least three prior lines of therapy.Who can participate: Participants must have a documented diagnosis of multiple myeloma and have received at least three prior lines of therapy. They …
1 - 10 of 17
- 1
- 2
Please choose between Voice or SMS based delivery of verification code
or